Symbols / TXMD Stock $2.08 +1.96% TherapeuticsMD, Inc.
TXMD (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteTherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Ratings
Current target
$2.08
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-17 | reit | Cantor Fitzgerald | Neutral → Neutral | $5 |
| 2022-07-13 | reit | Cantor Fitzgerald | — → Neutral | $1 |
| 2022-06-07 | down | HC Wainwright & Co. | Buy → Neutral | $10 |
- Drug-royalty owner TherapeuticsMD turns Q1 profit, explores sale, merger options - Stock Titan ue, 12 May 2026 20
- TXMD Reports Strong Q1 Revenue Growth and Explores Strategic Alt - GuruFocus Wed, 13 May 2026 04
- TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy - The Globe and Mail ue, 31 Mar 2026 07
- TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives - TipRanks ue, 12 May 2026 21
- TherapeuticsMD (TXMD) details Q1 2026 results and strategic review - Stock Titan ue, 12 May 2026 20
- TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Shared Momentum Picks - UBND thành phố Hải Phòng Wed, 22 Apr 2026 20
- TXMD Shares Surge on Strategic Developments - StocksToTrade Sat, 18 Oct 2025 07
- symbol__ Stock Quote Price and Forecast - CNN Wed, 30 Aug 2023 09
- TherapeuticsMD: Q1 Earnings Snapshot - marketscreener.com ue, 12 May 2026 20
- TXMD Forecast — Price Prediction for 2026. Should I Buy TXMD? - Intellectia AI Sat, 31 May 2025 12
- Therapeuticsmd Stock Price Forecast. Should You Buy TXMD? - StockInvest.us Wed, 02 Dec 2020 05
- TherapeuticsMD: From Fallen And Forgotten To Cash Cow - Seeking Alpha ue, 23 May 2023 07
- TherapeuticsMD - TXMD - Stock Price & News - The Motley Fool ue, 14 Sep 2021 09
- TXMD Stock Price and Chart — NASDAQ:TXMD - TradingView ue, 10 Oct 2017 22
- 3 Promising US Penny Stocks With Over $9M Market Cap - Yahoo Finance Fri, 03 Jan 2025 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
3.02
+71.61%
|
1.76
+35.25%
|
1.30
-98.14%
|
69.96
|
| Operating Revenue |
|
3.02
+71.61%
|
1.76
+35.25%
|
1.30
-98.14%
|
69.96
|
| Cost Of Revenue |
|
—
|
—
|
0.00
-100.00%
|
1.40
|
| Reconciled Cost Of Revenue |
|
—
|
—
|
0.02
-98.42%
|
1.39
|
| Gross Profit |
|
—
|
—
|
1.30
-98.10%
|
68.57
|
| Operating Expense |
|
7.24
+9.55%
|
6.61
-32.77%
|
9.82
-83.03%
|
57.90
|
| Research And Development |
|
—
|
—
|
—
|
0.00
|
| Selling General And Administration |
|
6.85
+12.40%
|
6.10
-31.53%
|
8.90
-84.30%
|
56.71
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
0.00
|
| General And Administrative Expense |
|
6.85
+12.40%
|
6.10
|
—
|
57.90
|
| Other Gand A |
|
6.85
+12.40%
|
6.10
|
—
|
57.90
|
| Total Expenses |
|
7.24
+9.55%
|
6.61
-32.77%
|
9.82
-83.43%
|
59.30
|
| Operating Income |
|
-4.21
+13.01%
|
-4.84
+43.17%
|
-8.52
-179.93%
|
10.66
|
| Total Operating Income As Reported |
|
-4.39
+28.17%
|
-6.11
+28.29%
|
-8.52
-815.62%
|
1.19
|
| EBITDA |
|
-3.02
+15.24%
|
-3.56
+53.11%
|
-7.60
-164.07%
|
11.86
|
| Normalized EBITDA |
|
-2.85
-23.91%
|
-2.30
+69.79%
|
-7.60
-135.63%
|
21.34
|
| Reconciled Depreciation |
|
1.19
-6.80%
|
1.28
+38.83%
|
0.92
-23.17%
|
1.20
|
| EBIT |
|
-4.21
+13.01%
|
-4.84
+43.17%
|
-8.52
-179.93%
|
10.66
|
| Total Unusual Items |
|
-0.18
+86.12%
|
-1.27
|
0.00
+100.00%
|
-9.47
|
| Total Unusual Items Excluding Goodwill |
|
-0.18
+86.12%
|
-1.27
|
0.00
+100.00%
|
-9.47
|
| Special Income Charges |
|
-0.18
+86.12%
|
-1.27
|
0.00
+100.00%
|
-9.47
|
| Impairment Of Capital Assets |
|
0.18
-86.12%
|
1.27
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
0.00
-100.00%
|
9.47
|
| Net Income |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Pretax Income |
|
-0.65
+72.13%
|
-2.34
+69.74%
|
-7.74
-820.86%
|
1.07
|
| Net Non Operating Interest Income Expense |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
—
|
| Net Interest Income |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Interest Expense |
|
—
|
—
|
—
|
—
|
| Interest Income Non Operating |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Interest Income |
|
0.14
+5.19%
|
0.14
|
—
|
—
|
| Other Income Expense |
|
3.42
+44.51%
|
2.37
+202.94%
|
0.78
+108.14%
|
-9.59
|
| Other Non Operating Income Expenses |
|
3.60
-1.07%
|
3.63
+365.30%
|
0.78
+767.52%
|
-0.12
|
| Tax Provision |
|
0.00
+100.00%
|
-0.03
+27.91%
|
-0.04
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+160.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
+100.00%
|
-0.02
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
-0.65
+71.76%
|
-2.31
+69.97%
|
-7.70
-816.85%
|
1.07
|
| Net Income From Continuing And Discontinued Operation |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Net Income Continuous Operations |
|
-0.65
+71.76%
|
-2.31
+69.97%
|
-7.70
-816.85%
|
1.07
|
| Net Income Discontinuous Operations |
|
0.08
-35.88%
|
0.13
+105.08%
|
-2.58
-102.33%
|
110.92
|
| Normalized Income |
|
-0.48
+55.02%
|
-1.06
+86.23%
|
-7.70
-173.00%
|
10.55
|
| Net Income Common Stockholders |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Diluted EPS |
|
—
|
-0.19
+80.61%
|
-0.98
-108.19%
|
11.96
|
| Basic EPS |
|
—
|
-0.19
+80.61%
|
-0.98
-107.90%
|
12.41
|
| Basic Average Shares |
|
—
|
11.53
+10.45%
|
10.44
+15.65%
|
9.03
|
| Diluted Average Shares |
|
—
|
11.53
+10.45%
|
10.44
+11.48%
|
9.37
|
| Diluted NI Availto Com Stockholders |
|
-0.57
+73.91%
|
-2.18
+78.78%
|
-10.28
-109.18%
|
112.00
|
| Depreciation Amortization Depletion Income Statement |
|
0.38
-24.56%
|
0.51
-44.79%
|
0.92
-22.72%
|
1.19
|
| Depreciation And Amortization In Income Statement |
|
0.38
-24.56%
|
0.51
-44.79%
|
0.92
-22.72%
|
1.19
|
| Total Other Finance Cost |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
37.66
-3.00%
|
38.82
-10.36%
|
43.31
-52.12%
|
90.46
|
| Current Assets |
|
14.45
+17.83%
|
12.26
+3.93%
|
11.80
-78.69%
|
55.35
|
| Cash Cash Equivalents And Short Term Investments |
|
7.48
+47.91%
|
5.06
+16.92%
|
4.33
-88.63%
|
38.07
|
| Cash And Cash Equivalents |
|
7.48
+47.91%
|
5.06
+16.92%
|
4.33
-88.63%
|
38.07
|
| Cash Financial |
|
—
|
—
|
—
|
38.07
|
| Receivables |
|
3.52
-1.04%
|
3.56
+15.28%
|
3.09
|
0.00
|
| Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Gross Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Other Receivables |
|
3.52
-1.04%
|
3.56
+15.28%
|
3.09
|
—
|
| Inventory |
|
—
|
—
|
—
|
—
|
| Raw Materials |
|
—
|
—
|
—
|
—
|
| Work In Process |
|
—
|
—
|
—
|
—
|
| Finished Goods |
|
—
|
—
|
—
|
—
|
| Prepaid Assets |
|
—
|
—
|
0.25
-78.32%
|
1.17
|
| Restricted Cash |
|
—
|
—
|
0.00
-100.00%
|
11.25
|
| Assets Held For Sale Current |
|
—
|
0.00
-100.00%
|
0.34
|
0.00
|
| Other Current Assets |
|
3.44
-5.53%
|
3.64
-9.84%
|
4.04
-33.13%
|
6.03
|
| Total Non Current Assets |
|
23.21
-12.62%
|
26.56
-15.71%
|
31.51
-10.24%
|
35.11
|
| Net PPE |
|
5.29
-13.26%
|
6.10
-11.22%
|
6.87
-10.25%
|
7.66
|
| Gross PPE |
|
5.29
-13.26%
|
6.10
-11.22%
|
6.87
-31.97%
|
10.10
|
| Accumulated Depreciation |
|
—
|
—
|
-2.52
-3.15%
|
-2.44
|
| Properties |
|
—
|
—
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
—
|
—
|
2.47
-0.04%
|
2.47
|
| Other Properties |
|
5.29
-13.26%
|
6.10
-11.22%
|
6.87
-9.33%
|
7.58
|
| Leases |
|
—
|
—
|
0.05
+0.00%
|
0.05
|
| Goodwill And Other Intangible Assets |
|
3.76
-12.96%
|
4.32
-29.14%
|
6.10
-12.17%
|
6.94
|
| Other Intangible Assets |
|
3.76
-12.96%
|
4.32
-29.14%
|
6.10
-12.17%
|
6.94
|
| Non Current Accounts Receivable |
|
13.71
-14.35%
|
16.01
-13.38%
|
18.48
-8.73%
|
20.25
|
| Other Non Current Assets |
|
0.44
+241.54%
|
0.13
+124.14%
|
0.06
-77.08%
|
0.25
|
| Total Liabilities Net Minority Interest |
|
10.78
-5.87%
|
11.45
-18.33%
|
14.02
-74.65%
|
55.31
|
| Current Liabilities |
|
4.79
-7.38%
|
5.17
-24.63%
|
6.85
-85.37%
|
46.84
|
| Payables And Accrued Expenses |
|
1.14
+51.99%
|
0.75
-55.42%
|
1.69
-90.93%
|
18.61
|
| Payables |
|
0.38
+46.12%
|
0.26
+855.56%
|
0.03
-98.75%
|
2.16
|
| Accounts Payable |
|
0.38
+46.12%
|
0.26
+855.56%
|
0.03
-98.75%
|
2.16
|
| Current Accrued Expenses |
|
0.77
+55.06%
|
0.49
-70.24%
|
1.66
-89.91%
|
16.45
|
| Current Debt And Capital Lease Obligation |
|
0.97
-40.29%
|
1.63
+10.86%
|
1.47
+5.97%
|
1.39
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.97
-40.29%
|
1.63
+10.86%
|
1.47
+5.97%
|
1.39
|
| Current Deferred Liabilities |
|
—
|
—
|
0.00
-100.00%
|
1.01
|
| Other Current Liabilities |
|
2.67
-4.10%
|
2.78
-24.72%
|
3.69
-85.70%
|
25.83
|
| Total Non Current Liabilities Net Minority Interest |
|
6.00
-4.63%
|
6.29
-12.30%
|
7.17
-15.43%
|
8.48
|
| Long Term Debt And Capital Lease Obligation |
|
5.12
-7.58%
|
5.54
-15.16%
|
6.53
-11.36%
|
7.37
|
| Long Term Capital Lease Obligation |
|
5.12
-7.58%
|
5.54
-15.16%
|
6.53
-11.36%
|
7.37
|
| Other Non Current Liabilities |
|
0.87
+17.34%
|
0.74
+16.98%
|
0.64
-42.55%
|
1.11
|
| Stockholders Equity |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Common Stock Equity |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Capital Stock |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
+22.22%
|
0.01
|
| Common Stock |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
+22.22%
|
0.01
|
| Preferred Stock |
|
—
|
—
|
—
|
0.00
|
| Share Issued |
|
11.57
+0.36%
|
11.53
0.00%
|
11.53
+21.42%
|
9.50
|
| Ordinary Shares Number |
|
11.57
+0.36%
|
11.53
0.00%
|
11.53
+21.42%
|
9.50
|
| Additional Paid In Capital |
|
979.26
+0.01%
|
979.18
+0.03%
|
978.92
+0.45%
|
974.50
|
| Retained Earnings |
|
-952.39
-0.06%
|
-951.82
-0.23%
|
-949.64
-1.09%
|
-939.36
|
| Total Equity Gross Minority Interest |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Total Capitalization |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Working Capital |
|
9.66
+36.19%
|
7.09
+43.52%
|
4.94
-41.94%
|
8.51
|
| Invested Capital |
|
26.88
-1.80%
|
27.37
-6.55%
|
29.29
-16.66%
|
35.14
|
| Total Debt |
|
6.10
-15.02%
|
7.17
-10.37%
|
8.01
-8.61%
|
8.76
|
| Net Debt |
|
—
|
—
|
—
|
—
|
| Capital Lease Obligations |
|
6.10
-15.02%
|
7.17
-10.37%
|
8.01
-8.61%
|
8.76
|
| Net Tangible Assets |
|
23.11
+0.29%
|
23.05
-0.60%
|
23.19
-17.77%
|
28.20
|
| Tangible Book Value |
|
23.11
+0.29%
|
23.05
-0.60%
|
23.19
-17.77%
|
28.20
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
2.45
+109.74%
|
1.17
+105.07%
|
-23.08
-346.62%
|
9.36
|
| Cash Flow From Continuing Operating Activities |
|
2.45
+109.74%
|
1.17
+105.07%
|
-23.08
-346.43%
|
9.37
|
| Cash From Discontinued Operating Activities |
|
—
|
—
|
—
|
-13.44
|
| Net Income From Continuing Operations |
|
-0.65
+71.76%
|
-2.31
+69.97%
|
-7.70
-816.85%
|
1.07
|
| Depreciation Amortization Depletion |
|
1.19
-6.80%
|
1.28
+38.83%
|
0.92
-23.17%
|
1.20
|
| Depreciation |
|
1.19
-6.80%
|
1.28
+1180.00%
|
0.10
-83.33%
|
0.60
|
| Amortization Cash Flow |
|
—
|
—
|
0.80
+33.33%
|
0.60
|
| Depreciation And Amortization |
|
1.19
-6.80%
|
1.28
+38.83%
|
0.92
-23.17%
|
1.20
|
| Amortization Of Intangibles |
|
—
|
—
|
0.80
+33.33%
|
0.60
|
| Other Non Cash Items |
|
—
|
-0.22
-69.77%
|
-0.13
+67.83%
|
-0.40
|
| Stock Based Compensation |
|
0.07
-71.59%
|
0.26
-79.23%
|
1.27
-89.02%
|
11.57
|
| Provisionand Write Offof Assets |
|
—
|
—
|
—
|
—
|
| Asset Impairment Charge |
|
0.18
-86.12%
|
1.27
|
0.00
|
—
|
| Change In Working Capital |
|
1.66
+148.21%
|
0.67
+103.84%
|
-17.45
-326.97%
|
-4.09
|
| Change In Receivables |
|
—
|
—
|
—
|
—
|
| Changes In Account Receivables |
|
—
|
—
|
—
|
—
|
| Change In Inventory |
|
—
|
—
|
—
|
—
|
| Change In Prepaid Assets |
|
0.20
-49.37%
|
0.40
-80.14%
|
2.00
+222.42%
|
0.62
|
| Change In Payables And Accrued Expense |
|
0.39
+150.45%
|
-0.78
+95.66%
|
-17.85
-684.99%
|
3.05
|
| Change In Accrued Expense |
|
0.27
+127.04%
|
-1.01
+93.60%
|
-15.71
-468.68%
|
4.26
|
| Change In Payable |
|
0.12
-48.48%
|
0.23
+110.82%
|
-2.13
-76.30%
|
-1.21
|
| Change In Account Payable |
|
0.12
-48.48%
|
0.23
+110.82%
|
-2.13
-76.30%
|
-1.21
|
| Change In Other Current Assets |
|
2.02
+4.66%
|
1.93
+271.40%
|
-1.13
+85.25%
|
-7.64
|
| Change In Other Current Liabilities |
|
-0.95
-7.60%
|
-0.88
-87.26%
|
-0.47
-289.26%
|
-0.12
|
| Investing Cash Flow |
|
—
|
—
|
0.00
+100.00%
|
-0.35
|
| Cash Flow From Continuing Investing Activities |
|
—
|
—
|
0.00
+100.00%
|
-0.35
|
| Cash From Discontinued Investing Activities |
|
—
|
—
|
—
|
223.83
|
| Net PPE Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Purchase Of PPE |
|
—
|
—
|
—
|
0.00
|
| Capital Expenditure |
|
—
|
—
|
—
|
-0.35
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-0.35
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
-0.35
|
| Financing Cash Flow |
|
—
|
0.00
-100.00%
|
3.15
+101.34%
|
-235.21
|
| Cash Flow From Continuing Financing Activities |
|
—
|
0.00
-100.00%
|
3.15
+101.34%
|
-235.21
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Net Long Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-219.43
|
| Short Term Debt Payments |
|
—
|
—
|
—
|
-219.43
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
-219.43
|
| Net Common Stock Issuance |
|
—
|
0.00
-100.00%
|
3.15
+27.67%
|
2.47
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
+100.00%
|
-38.66
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
-1.27
|
| Changes In Cash |
|
2.42
+231.15%
|
0.73
+101.63%
|
-44.99
-184.66%
|
-15.80
|
| Beginning Cash Position |
|
5.06
+16.92%
|
4.33
-91.23%
|
49.32
-24.27%
|
65.12
|
| End Cash Position |
|
7.48
+47.91%
|
5.06
+16.92%
|
4.33
-91.23%
|
49.32
|
| Free Cash Flow |
|
2.45
+109.74%
|
1.17
+105.07%
|
-23.08
-356.34%
|
9.00
|
| Interest Paid Supplemental Data |
|
—
|
—
|
0.00
-100.00%
|
13.54
|
| Common Stock Issuance |
|
—
|
0.00
-100.00%
|
3.15
+27.67%
|
2.47
|
| Issuance Of Capital Stock |
|
—
|
0.00
-100.00%
|
3.15
-86.95%
|
24.15
|
| Net Preferred Stock Issuance |
|
—
|
—
|
0.00
+100.00%
|
-16.97
|
| Preferred Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
21.68
|
| Preferred Stock Payments |
|
—
|
—
|
0.00
+100.00%
|
-38.66
|
| Cash Flow From Discontinued Operation |
|
-0.03
+93.15%
|
-0.44
+98.25%
|
-25.06
-111.91%
|
210.40
|
| Cash From Discontinued Financing Activities |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-05-12 View
- 8-K2026-05-12 View
- 8-K2026-03-30 View
- 10-K2026-03-30 View
- 8-K2026-01-21 View
- 42025-12-29 View
- 8-K2025-12-16 View
- 8-K2025-11-13 View
- 10-Q2025-11-12 View
- 42025-11-05 View
- 42025-11-05 View
- 42025-11-05 View
- 42025-11-05 View
- 10-Q2025-08-12 View
- 8-K2025-08-12 View
- 10-Q2025-05-13 View
- 8-K2025-05-13 View
- 42025-04-15 View
- 42025-04-15 View
- 42025-04-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|